Akouos AKUS Stock
Akouos Price Chart
Akouos AKUS Financial and Trading Overview
| Akouos stock price | 13.29 USD |
| Previous Close | 13.29 USD |
| Open | 13.2 USD |
| Bid | 13.28 USD x 800 |
| Ask | 13.8 USD x 800 |
| Day's Range | 13.16 - 13.33 USD |
| 52 Week Range | 2.32 - 13.6 USD |
| Volume | 1.79M USD |
| Avg. Volume | 725.97K USD |
| Market Cap | 458.42M USD |
| Beta (5Y Monthly) | -1.479957 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.33 USD |
AKUS Valuation Measures
| Enterprise Value | 326.18M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.9962406 |
| PEG Ratio (5 yr expected) | -0.15 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.7891761 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.508 |
Trading Information
Akouos Stock Price History
| Beta (5Y Monthly) | -1.479957 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 13.6 USD |
| 52 Week Low | 2.32 USD |
| 50-Day Moving Average | 11.93 USD |
| 200-Day Moving Average | 5.81 USD |
AKUS Share Statistics
| Avg. Volume (3 month) | 725.97K USD |
| Avg. Daily Volume (10-Days) | 496.11K USD |
| Shares Outstanding | 34.49M |
| Float | 23.4M |
| Short Ratio | 16.36 |
| % Held by Insiders | 1.12% |
| % Held by Institutions | 95.70% |
| Shares Short | 2.26M |
| Short % of Float | 9.47% |
| Short % of Shares Outstanding | 6.12% |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.36% |
| Return on Equity (ttm) | -40.32% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -92985000 USD |
| Net Income Avi to Common (ttm) | -95659000 USD |
| Diluted EPS (ttm) | -2.164 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 192.9M USD |
| Total Cash Per Share (mrq) | 5.23 USD |
| Total Debt (mrq) | 32.75M USD |
| Total Debt/Equity (mrq) | 16.54 USD |
| Current Ratio (mrq) | 13.36 |
| Book Value Per Share (mrq) | 7.428 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -72758000 USD |
| Levered Free Cash Flow (ttm) | -54384500 USD |
Profile of Akouos
| Country | United States |
| State | MA |
| City | Boston |
| Address | 645 Summer Street |
| ZIP | 02210 |
| Phone | 857 410 1818 |
| Website | https://www.akouos.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 103 |
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
Q&A For Akouos Stock
What is a current AKUS stock price?
Akouos AKUS stock price today per share is 13.29 USD.
How to purchase Akouos stock?
You can buy AKUS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Akouos?
The stock symbol or ticker of Akouos is AKUS.
Which industry does the Akouos company belong to?
The Akouos industry is Biotechnology.
How many shares does Akouos have in circulation?
The max supply of Akouos shares is 36.95M.
What is Akouos Price to Earnings Ratio (PE Ratio)?
Akouos PE Ratio is 0.00000000 now.
What was Akouos earnings per share over the trailing 12 months (TTM)?
Akouos EPS is 0 USD over the trailing 12 months.
Which sector does the Akouos company belong to?
The Akouos sector is Healthcare.
Akouos AKUS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}